Persius/hicric huggingface dataset:
Appeal type: unknown
Decision: unknown

The rules say that plans must pay for a medical service or item if regular Medicare would pay for it in this case.
You can find this rule at 42 CFR 422.101.
The rules say that Medicare may cover a drug or biological if it is safe and effective and otherwise reasonable
and necessary. You can find this rule in the Medicare Benefit Policy Manual, Chapter 15, Section 50.4.1.
Medicare rules also allow the plan to use step therapy. This is the process of beginning drug therapy for a
medical condition with "preferred" (or more cost-effective) on-formulary drug alternative(s) and progressing to
other drug therapies only as necessary. A plan must grant an exception to its step therapy rules if it determines
that the requested drug is medically necessary, consistent with the prescriber's statement. The statement must
show that the step therapy drugs: have been ineffective in treating the enrollee; or are likely to be ineffective or
adversely affect the drug's effectiveness or patient compliance; or are likely to cause an adverse reaction or
other harm to the enrollee.
Medicare Advantage plans should ensure that new step therapy requirements do not disrupt ongoing Part B
drug therapies for enrollees. Step therapy may only be applied to new prescriptions or administrations of Part B
drugs for enrollees that are not actively receiving the affected medication. You can find this information at 42
CFR Section 423.578(b)(5)(ii).
If you want to read these Medicare rules, you can go to this web site www.medicareappeal.com.
The Plan contract says that the Plan covers items and services in accordance with Medicare rules. The contract
says that the Plan has step therapy requirements for certain Medicare Part B covered drugs/biologicals.
Enrollees may be required to try a preferred drug before the Plan will approve the requested medication. You
can find this information on pages 141-142 of the plan's 2019 Evidence of Coverage.
Appeal type: unknown
Decision: unknown

The rules say that plans must pay for a medical service or item if regular Medicare would pay for it in this case. You can find this rule at 42 CFR 422.101.The rules state that procedure code 0466T -insertion of a chest wall respiratory sensor such as the Inspire procedure -is not considered medically necessary and is not covered by Medicare at this time. You can find this rule in Local Coverage Article (LCA) Billing and Coding: Non-Covered Category III CPT Codes (A56480).If you want to read these Medicare rules, you can go to this web site www.medicareappeal.com.The Plan contract says that the Plan covers items and services in accordance with Medicare rules.
Appeal type: unknown
Decision: unknown

Medicare rulesThe rules say that plans must pay for a medical service or item if regular Medicare would pay for it in this case. You can find this rule at 42 CFR ?422.101.The rules say that the provider must notify the enrollee in writing before a Medicare plan ends coverage of skilled nursing facility services. A Notice of Medicare Non-Coverage (NOMNC) must be issued no later than two days before the last covered day. The notice must state:1. The date that coverage of services ends,2. The date that the enrollee must begin to pay for the services, and3. A description of the enrollee's right to a fast-track appeal and other appeal procedures.The Medicare plan must continue to cover services until two days after valid notice is delivered. You can find this rule at 42 CFR ?422.624.The rules say that notification of changes for an enrollee who is incapable of receiving or incompetent to receive the notice must be made to a representative of the enrollee. You can find these rules in the Medicare Claims Processing Manual, Chapter 30, Section 260.3.8.If you want to read these Medicare rules, you can go to this web site www.medicareappeal.com.The Plan contract says that the Plan covers items and services in accordance with Medicare rules.
Appeal type: unknown
Decision: unknown

The rules say that plans must pay for a medical service or item if regular Medicare would pay for it in this case.
You can find this rule at 42 CFR 422.101.
The rules say that an inpatient admission is generally appropriate when the admitting physician expects the
patient to need hospital care that crosses at least two midnights. The expectation should be based on such
complex medical factors as medical history, the severity of signs and symptoms, current medical needs, and
medical risk. The factors must be documented in the medical record.
If an unforeseen event, such as a patient's death or transfer, results in a shorter stay, the patient may be
considered to be treated as an inpatient. An inpatient admission for a surgical procedure listed by Medicare as
"inpatient only" is generally appropriate, regardless of the length of stay. An inpatient admission may be
appropriate if the admitting physician expects a patient to require hospital care for only a limited period of
time. The decision to admit as an inpatient must be based on the clinical judgment of the physician and must be
supported by the medical record. You can find this rule at 42 CFR 412.3.
If you want to read these Medicare rules, you can go to this web site www.medicareappeal.com.
The Plan contract says that the Plan covers items and services in accordance with Medicare rules.
Appeal type: unknown
Decision: unknown

The rules say that plans must pay for a medical service or item if regular Medicare would pay for it in this case. You can find this rule at 42 CFR ?422.101. The rules state that the coverage indications for facet joint block injections are:&#61623;Patient must have history of at least 3 months of moderate to severe pain with functional impairment and pain is inadequately responsive to conservative care such as NSAIDs, acetaminophen, physical therapy (as tolerated).&#61623;Pain is predominantly axial and, with the possible exception of facet joint cysts, not associated with radiculopathy or neurogenic claudication.&#61623;There is no non-facet pathology that could explain the source of the patient's pain, such as fracture, tumor, infection, or significant deformity.&#61623;Clinical assessment implicates the facet joint as the putative source of pain.You can find these rules in Local CoverageDetermination (LCD) Facet Joint Injections, Medial Branch Blocks, and Facet Joint Radiofrequency Neurotomy (L35936).If you want to read these Medicare rules, you can go to this web site www.medicareappeal.com.The Plan contract says that the Plan covers items and services in accordance with Medicare rules.
Appeal type: unknown
Decision: unknown

The rules say that plans must pay for a medical service or item if regular Medicare would pay for it in this case.
You can find this rule at 42 CFR 422.101.
The rules say that physical therapy (PT), occupational therapy (OT), and speech therapy (ST) services are
covered only when they are medically reasonable and necessary. Therapy services are considered reasonable
and necessary when:
1. The services are specific and effective treatment for the patient's condition,
2. The services require the skills or direct supervision of a therapist,
3. The amount, frequency, and duration of the services is reasonable under accepted standards of practice, and
4. The services are needed to address recovery of or improvement in function OR to establish, design, deliver,
or carry out a maintenance program.
Medicare coverage is based not on a patient's potential for improvement, but rather on the patient's need for
skilled care. You can find these rules in the Local Coverage Determination (LCD) for Therapy and
Rehabilitation Services (PT, OT), L35036. This LCD is effective for services provided on or after November
14, 2019.
If you want to read these Medicare rules, you can go to this web site www.medicareappeal.com.
The Plan contract says that the Plan covers items and services in accordance with Medicare rules.
Appeal type: unknown
Decision: unknown

The rules say that plans must pay for a medical service or item if regular Medicare would pay for it in this case. You can find this rule at42 CFR?422.101.The rules state that MA plans may specify brands and manufacturers as preferred and charge lower cost-sharing for the preferred brands or may limit the DME to only those preferred brands and manufacturers as long as the enrollee retains access to all medically necessary items (including non-preferred brands). You can find this information in the Medicare Managed Care Manual Chapter 4, Section 10.12.2.If you want to read these Medicare rules, you can go to this web site www.medicareappeal.com.The Plan contract says that the Plancovers items and services in accordance with Medicare rules.The contract says that the Plan only covers certain brands of diabetic test strips unless alternate brand strips are medically necessary for some reason. The preferred brands are ACCU-CHEK by Roche or Trividia brand which is sometimes packaged under the pharmacy's name. You can find this information on page 67 of the 2020 EOC
Appeal type: unknown
Decision: unknown

The rules say that plans must pay for a medical service or item if regular Medicare would pay for it in this case.
You can find this rule at 42 CFR 422.101.
The rules state that cardiovascular nuclear medicine is indicated for the following:
&#61623; Assessment of the functional and prognostic importance of angina;
&#61623; Diagnostic evaluation of patients with chest pain and uninterpretable or equivocal electrocardiogram
(EKG) changes caused by drugs, bundle branch block, or left ventricular hypertrophy;
&#61623; Assessment of congenital anomalies of coronary arteries;
&#61623; Risk assessment or re-evaluation of disease in patients who are asymptomatic or have stable symptoms,
with known atherosclerotic heart disease on catheterization or SPECT perfusion imaging, who have not
had a revascularization procedure within the past two years;
&#61623; Detection of coronary artery disease in patients, without chest pain syndrome, with new-onset of
diagnosed heart failure or left ventricular systolic dysfunction;
&#61623; Evaluation of ischemic versus non-ischemic cardiomyopathy when cardiac catheterization / coronary
angiography are not planned;
&#61623; Evaluation of myocardial perfusion and/or function before and after coronary artery bypass surgery or
other re-perfusion procedures;
&#61623; Quantification and surveillance of myocardial infarction and prognostication in patients with infarction;
&#61623; Assessment of congenital anomalies of coronary arteries;
&#61623; Preoperative assessment for non-cardiac surgery, when used to determine risk for surgery and/or
perioperative management under certain conditions for certain procedures;
&#61623; Evaluation of ventricular function in patients with non-ischemic myocardial disease;
&#61623; Evaluation of patients in whom an accurate measure of the ejection fraction is needed to make a
determination of whether to implant a defibrillator or biventricular pacemaker;
&#61623; Evaluation of a patient receiving chemotherapeutic drugs which are potentially cardiotoxic (e.g.,
adriamycin).
Tests performed when the results would not be anticipated to influence medical management decisions will be
denied as not medically necessary. You can find these rules in Local Coverage Determination (LCD)
Cardiovascular Nuclear Medicine (L33560).
If you want to read these Medicare rules, you can go to this web site www.medicareappeal.com.
The Plan contract says that the Plan covers items and services in accordance with Medicare rules.
Appeal type: unknown
Decision: unknown

The rules say that plans must pay for a medical service or item if regular Medicare would pay for it in this case.
You can find this rule at 42 CFR 422.101.
The rules state that the following are indications of total knee arthroplasty:
Advanced joint disease demonstrated by:
- Radiographic supported evidence or when conventional radiography is not adequate, magnetic resonance
imaging (MRI) and/or computed tomography (CT) (in situations when MRI is non-diagnostic or not able to be
performed) supported evidence (subchondral cysts, subchondral sclerosis, periarticular osteophytes, joint
subluxation, joint space narrowing, avascular necrosis); and
- Pain or functional disability from injury due to trauma or arthritis of the joint; and
- If appropriate, history of unsuccessful conservative therapy (non-surgical medical management) that is clearly
addressed in the pre-procedure medical record. (If conservative therapy is not appropriate, the medical record
must clearly document why such approach is not reasonable). Non-surgical medical management is usually but
not always implemented prior to scheduling total joint surgery. Non-surgical treatment as clinically appropriate
for the patient's current episode of care typically includes one or more of the following:
- anti-inflammatory medications or analgesics, or
- flexibility and muscle strengthening exercises, or
- supervised physical therapy [Activities of daily living (ADLs) diminished despite completing a plan of care],
or
- assistive device use, or
- weight reduction as appropriate, or
- therapeutic injections into the knee as appropriate.
In some circumstances, for example, if the patient has bone on bone articulation, severe deformity, pain or
significant disabling interference with activities of daily living, the surgeon may determine that nonsurgical
medical management would be ineffective or counterproductive, and that the best treatment option, after
explaining the risks, is surgical. If medical management is deemed inappropriate, the medical record should
indicate the rationale for and circumstances under which this is the case.
- Failure of a previous osteotomy; or
- Distal femur fracture; or
- Malignancy of the distal femur, proximal tibia, knee joint or adjacent soft tissues; or
- Failure of previous unicompartmental knee replacement; or
- Avascular necrosis of the knee; or
- Proximal tibia fracture
You can find these rules in the Local Coverage Determination (LCD) for Total Knee Arthroplasty, L36577.
This LCD is effective for services provided on or after December 1, 2019.
If you want to read these Medicare rules, you can go to this web site www.medicareappeal.com.
The Plan contract says that the Plan covers items and services in accordance with Medicare rules.
Appeal type: unknown
Decision: unknown

The rules say that plans must pay for a medical service or item if regular Medicare would pay for it in this case. You can find this rule at 42 CFR ?422.101.The rules state that coverage and payment for Medicaretelehealth services includes consultation, office visits, individual psychotherapy, and pharmacologic management delivered via a telecommunications system. Eligible geographic areas include rural health professional shortage areas (HPSA) and counties not classified as a metropolitan statistical area (MSA). The originating site for telehealth services (location to which the enrollee presents) must be a practitioner's office, hospital, rural health clinic (RHC), federally qualified health center (FQHC), skilled nursing facility or community mental health center. You can find this rule in the Medicare Claims Processing Manual, Chapter 12, Sections 190.1 and 190.2.The rules say that for eligible telehealth services, telecommunications systems substitute for an in-person encounter. Medicare enrollees are eligible for telehealth services only if they are presented from an originating site located in either a county outside of a Metropolitan Statistical Area (MSA) or a rural Health Professional Shortage Area (HPSA) located in a rural census tract. You can find this in the CMS MLN document entitled "Telehealth Services."If you want to read these Medicare rules, you can go to this web site www.medicareappeal.com.The Plan contract says that the Plancovers items and services in accordance with Medicare rules.
Appeal type: unknown
Decision: unknown

The rules say that plans must pay for a medical service or item if regular Medicare would pay for it in this case. You can find this rule at 42 CFR ?422.101.The rules say that Medicare will pay for an IRF admission when the services are reasonable and medically necessary. The patient must require an intensive and coordinated interdisciplinary approach to providing rehabilitation. The patient must need active and ongoingtreatment by more than one therapy discipline. One of the therapies must be physical therapy or occupational therapy. The patient must need and be expected to actively participate in and to benefit from an intensive rehabilitation therapy program. This intensive rehabilitation therapy program generally consists of at least three hours of therapy per day at least five days per week. The patient does not need to be expected to achieve complete independence in self-care nor be expected to return to his or herprior level of functioning. The patient must need supervision by a rehabilitation physician. The physician must see the patient at least three days per week throughout the stay. You can find these rules in the Medicare Benefit Policy Manual, Chapter 1, Sections 110.2 and 110.2.5 and at 42 CFR ?412.622.If you want to read these Medicare rules, you can go to this web site www.medicareappeal.com.The Plan contract says that the Plan covers items and services in accordance with Medicare rules.
Appeal type: unknown
Decision: unknown

The rules say that plans must pay for a medical service or item if regular Medicare would pay for it in this case. You can find this rule at 42 CFR 422.101.
The rules say that Medicare pays for therapeutic continuous glucose monitors (CGMs) when they are medically reasonable and necessary. Therapeutic CGMs are defined in CMS Ruling 1682R. You can find these rules in Local Coverage Article A52464, effective on and after January 12, 2017. CGMs consist of three components: a glucose sensor, a transmitter, and a receiver. CGMs are considered therapeutic CGMs if they are: - approved by the FDA for use in place of a blood glucose monitor for making diabetes treatment decisions (for example, changes in diet and insulin dosage); - generally not useful to the individual in the absence of an illness or injury; - appropriate for use in the home; and - those which include a durable component that can withstand repeated use, are expected to last at least three years, and are capable of displaying the trending of the continuous glucose measurements. The rules also say that a CGM which does not replace a blood glucose monitor for making diabetes treatment decisions is not covered. You can find these rules in CMS Ruling 1682R.
If you want to read these Medicare rules, you can go to this web site www.medicareappeal.com.
The Plan contract says that the Plan covers items and services in accordance with Medicare rules.
Appeal type: unknown
Decision: unknown

The rules say that plans must pay for a medical service or item if regular Medicare would pay for it in this case. You can find this rule at 42 CFR ?422.101.The rules say a health plan must disclose to its enrollees in clear, accurate terms all cost-sharing information (such as copayments, deductibles and coinsurance). You can find this rule at 42 CFR ?422.111(a) and (b).The rules say that a copayment is a fixed amount charged to an enrollee on a per-service basis. The rules say that coinsurance is a fixed percentage of the total amount paid for a health care service that can be charged to an enrollee on a per-service basis. You can find this rule at 42 CFR ?422.2.If you want to read these Medicare rules, you can go to this web site www.medicareappeal.com.The Plancontract says that the Plan covers items and services in accordance with Medicare rules. The Plan contract says that enrollees must pay a $250 copayment for outpatient surgery/outpatient hospital facility. You can find this information on page 70 of the Plan's 2019 Evidence of Coverage.
Appeal type: unknown
Decision: unknown

The rules say that plans must pay for a medical service or item if regular Medicare would pay for it in this case. You can find this rule at 42 CFR ?422.101.The rules say that the supplier for all Durable Medical Equipment, Prosthetic, and Orthotic Supplies (DMEPOS) must have an order from the treating physician before giving any DMEPOS item to an enrollee. The supplier must keep the order and proof of delivery documentation on file. All services that do not have appropriate proof of delivery will be denied. You can find this rule in the MedicareProgram Integrity Manual, Chapter 5, Sections 5.2.1 and 5.8.The rules say if you utilize a shipping service or mail order, the POD documentation must be a complete record tracking the item(s) from you to the beneficiary. An example of acceptable proof of delivery would include both your detailed shipping invoice and the delivery service's tracking information. Your record must be linked to the delivery service record by some clear method like the delivery service's package identification number or your invoice number for the package sent to the beneficiary. The POD document must include: - Beneficiary's name - Delivery address - Delivery service's package identification number, your invoice number, or alternative method that links your delivery documents with the delivery service's records - Sufficiently detailed description to identify the item(s) being delivered (e.g., brand name, serial number, narrative description). The long description of the HCPCS code, may be used as a means to provide a detailed description of the item being delivered. - Quantity delivered - Date delivered - Evidence of delivery If you utilize a shipping service or mail order, you must use the shipping date as the DOS on the claim. The shipping date may be defined as the date the delivery/shipping service label is created or the date the item is retrieved for delivery. However, such dates should not demonstrate significant variation. You can find this information in Local Coverage Article: Standard Documentation Requirements for All Claims Submitted to DME MACs (A55426).If you want to read these Medicare rules, you can go to this web site www.medicareappeal.com.The Plan contract says that the Plan covers items and services in accordance with Medicare rules.
Appeal type: unknown
Decision: unknown

The rules say that plans must pay for a medical service or item if regular Medicare would pay for it in this case. You can find this rule at 42 CFR ?422.101.The rules say that although thedetection of elevated CTCs during therapy is a definitive indication of subsequent rapid disease progression and mortality in breast, colorectal and prostate cancer, no data has been forthcoming to demonstrate improved patient outcomes, or that the assay changes physician management to demonstrate improved patient outcomes. CTC testing for all malignant diagnoses will be denied as not reasonable and necessary. You can find this rule at Local Coverage Determination (LCD): MolDX: Circulating Tumor Cell Marker Assays (L35710 (eff. 9/24/18).If you want to read these Medicare rules, you can go to this web site www.medicareappeal.com.The Plan contract says that the Plan covers items and services in accordance with Medicare rules.
Appeal type: unknown
Decision: unknown

The rules say that plans must pay for a medical service or item if regular Medicare would pay for it in this case. You can find this rule at 42 CFR 422.101.Medicare may cover the use of an FDA-approved drug or biological if it is safe and effective and otherwise reasonable and necessary for the patient. FDA approved drugs used for indications other than what is indicated on the official label may be covered if the use is determined to be medically accepted, taking into consideration the major drug compendia, authoritative medical literature and/or accepted standards of medical practice. You can find this rule in the Medicare Benefit Policy Manual, Chapter 15, Sections 50.4.1 and 50.4.2.If you want to read these Medicare rules, you can go to this web site www.medicareappeal.com.The Plan contract says that the Plancovers items and services in accordance with Medicare rules.